Medications not yet evaluated by P&T are considered NON-FORMULARY . . . . . Always check 2 unique patient identifiers - NAME and DATE OF BIRTH - at every step! . . . . . Please be sure to document all clinical activities daily.
Search results for:

disopyramide

disopyramide
Drug Name Form Strength Formulary Unrestricted Formulary Restricted Non-Formulary Interchange
Norpace CR CAPSULE, EXTENDED RELEASE, ORAL 100 mg, 150 mg    
Norpace CAPSULE, ORAL 100 mg, 150 mg      
Comments:

ORDERED FORMULATION

THERAPEUTIC INTERCHANGE

disopyramide (Norpace CR)

  • All formulations

disopyramide (Norpace)

  • CR should be converted to the IR form in the same daily dose (divide into 6qh doses)

Reviewed: December 11, 2012

Last updated: Nov. 16, 2022
  • Black Box Warning: Mortality Risk
  • Formulary, Not Routinely Stocked: 100 mg capsule






This site is intended for the staff of Huntsville Hospital.
While others may view accessible pages, Huntsville Hospital makes no warranty, express or implied,
as to the use of this information outside of Huntsville Hospital.
Please note than many documents are accessible via the provided link
only when connected to the Huntsville Hospital intranet.

Copyright © 2024 Rpharmy, LLC ­ All Rights Reserved